Study of Prophylactic Vs Preemptive Valganciclovir

NCT00374686 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Cytomegalovirus Infection

Interventions

DRUG: Valganciclovir

Sponsor

Washington University School of Medicine

Collaborators

[object Object]